Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Research Article

The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population.

Jennifer L. Beebe-Dimmer, Terrance L Albrecht, Tara E. Baird, Julie J Ruterbusch, Theresa Hastert, Felicity W. K. Harper, Michael S. Simon, Judith Abrams, Kendra L. Schwartz and Ann G. Schwartz
Jennifer L. Beebe-Dimmer
Department of Oncology, Wayne State University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dimmerj@karmanos.org
Terrance L Albrecht
Oncology, Cancer Institute/Wayne State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara E. Baird
Department of Oncology, Wayne State University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie J Ruterbusch
Oncology, Wayne State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theresa Hastert
Oncology, Karmanos Cancer Institute/Wayne State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Theresa Hastert
Felicity W. K. Harper
Population Studies and Disparities Research Program, Karmanos Cancer Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Felicity W. K. Harper
Michael S. Simon
Oncology, Karmanos Cancer Institute, Wayne State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael S. Simon
Judith Abrams
Oncology, Wayne State University-Karmanos Cancer Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kendra L. Schwartz
Fam Med & Pub Health Sci, Wayne State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann G. Schwartz
Department of Oncology, Karmanos Cancer Institute, Wayne State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ann G. Schwartz
DOI: 10.1158/1055-9965.EPI-18-0123
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background:African Americans are often diagnosed with advanced stage cancer and experience higher mortality compared with whites in the United States. Contributing factors, like differences in access to medical care and the prevalence of comorbidities, do not entirely explain racial differences in outcomes. Methods:The Detroit Research on Cancer Survivors (ROCS) pilot study was conducted to investigate factors related to short and long term outcomes among cancer patients. Participants completed web-based surveys and mailed saliva specimens were collected for future genetic studies. Results:We recruited 1,000 participants with an overall response rate of 68%. Thirty-one percent completed the survey without any interviewer support and the remaining participated in an interviewer-administered survey. Seventy-four percent provided a saliva specimen and 64% consented for tumor tissue retrieval. African American survivors required more interviewer support (p<0.001), however their response rate (69.6%) was higher than non-Hispanic whites (65.4%). African Americans reported poorer overall cancer-related quality of life compared with non-Hispanic whites, measured by FACT-G score (p<0.001), however , this relationship was reversed after controlling for socioeconomic factors, marital status, and the presence of comorbidities. Conclusions:In this pilot study, we demonstrated that a web-based survey supplemented with telephone interviews and mailed saliva kits are cost-effective methods to collect patient-reported data and DNA for large studies of cancer survivors with a high proportion of minority patients. Impact:The preliminary data collected reinforces differences by race in factors affecting cancer outcomes. Our efforts continue as we expand this unique cohort to include more than 5,000 African American cancer survivors.-

  • Received January 25, 2018.
  • Revision received June 4, 2018.
  • Accepted November 20, 2018.
  • Copyright ©2018, American Association for Cancer Research.
PreviousNext
Back to top

Published OnlineFirst November 27, 2018
doi: 10.1158/1055-9965.EPI-18-0123

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population.
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
Citation Tools
The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population.
Jennifer L. Beebe-Dimmer, Terrance L Albrecht, Tara E. Baird, Julie J Ruterbusch, Theresa Hastert, Felicity W. K. Harper, Michael S. Simon, Judith Abrams, Kendra L. Schwartz and Ann G. Schwartz
Cancer Epidemiol Biomarkers Prev November 27 2018 DOI: 10.1158/1055-9965.EPI-18-0123

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population.
Jennifer L. Beebe-Dimmer, Terrance L Albrecht, Tara E. Baird, Julie J Ruterbusch, Theresa Hastert, Felicity W. K. Harper, Michael S. Simon, Judith Abrams, Kendra L. Schwartz and Ann G. Schwartz
Cancer Epidemiol Biomarkers Prev November 27 2018 DOI: 10.1158/1055-9965.EPI-18-0123
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Hepatocellular Carcinoma Incidence in California
  • IL6, YKL-40, and CRP in Pancreatic Cancer
  • The VIRUSCAN Study
Show more Research Article
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement